XML 116 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Total revenues $ 2,502,470,000 $ 2,376,117,000 $ 2,018,197,000
Total cost of revenues 1,750,151,000 1,645,798,000 1,341,446,000
Gross profit 752,319,000 730,319,000 676,751,000
Operating expenses      
Sales, general and administrative 346,872,000 423,210,000 325,264,000
Research and development 202,200,000 207,905,000 169,407,000
Amortization of intangible assets 64,286,000 71,713,000 20,785,000
Restructuring 6,278,000 77,183,000 6,418,000
Total operating expenses 619,636,000 780,011,000 521,874,000
Operating income (loss) 132,683,000 (49,692,000) 154,877,000
Other income (expense)      
Interest income 1,849,000 2,153,000 2,126,000
Interest expense (52,453,000) (58,203,000) (13,845,000)
Other income (expense), net (9,047,000) (3,409,000) (8,583,000)
Total other income (expense) (59,651,000) (59,459,000) (20,302,000)
Total income before income taxes 73,032,000 (109,151,000) 134,575,000
Income tax benefit (provision) (20,617,000) 12,570,000 (74,326,000)
Net income (loss) 52,415,000 (96,581,000) 60,249,000
Net income attributable to noncontrolling interests 3,409,000 2,669,000 2,951,000
Net income (loss) attributable to Itron, Inc. $ 49,006,000 $ (99,250,000) $ 57,298,000
Earnings (loss) per common share - Basic (in dollars per share) $ 1.24 [1] $ (2.53) [1] $ 1.48
Earnings (loss) per common share - Diluted (in dollars per share) $ 1.23 [1] $ (2.53) [1] $ 1.45
Weighted average common shares outstanding - Basic (in shares) 39,556 39,244 38,655
Weighted average common shares outstanding - Diluted (in shares) 39,980 39,244 39,387
Product [Member]      
Total revenues $ 2,220,395,000 $ 2,095,458,000 $ 1,813,925,000
Total cost of revenues 1,587,710,000 1,476,498,000 1,204,127,000
Service [Member]      
Total revenues 282,075,000 280,659,000 204,272,000
Total cost of revenues $ 162,441,000 $ 169,300,000 $ 137,319,000
[1] The sum of the quarterly EPS data presented in the table may not equal the annual results due to rounding and the impact of dilutive securities on the annual versus the quarterly EPS calculations.